Zhengye Biotechnology Holding (ZYBT) Enterprise Value (2023 - 2025)
Zhengye Biotechnology Holding (ZYBT) posted quarterly Enterprise Value of $701156.2 for Q4 2025, down 89.62% year-over-year from $6.8 million in Q4 2024, and down 73.56% quarter-over-quarter from $2.7 million in Q2 2025.
Zhengye Biotechnology Holding (ZYBT) Enterprise Value (2023 - 2025) Analysis & Trends
Zhengye Biotechnology Holding (ZYBT) has reported Enterprise Value for 3 consecutive years, with $701156.2 the latest figure, recorded in Q4 2025.
- In Q4 2025, Enterprise Value fell 89.62% year-over-year to $701156.2; the TTM figure through Dec 2025 stood at $701156.2 (down 89.62% YoY), while the FY2025 annual figure was $815330.0, down 87.53% from the prior year.
- Enterprise Value slipped to $701156.2 in Q4 2025 per ZYBT's latest filing, from $2.7 million in the prior quarter.
- Across five years, Enterprise Value topped out at $6.8 million in Q4 2024 and bottomed at $701156.2 in Q4 2025.
- Historically, Enterprise Value has averaged $3.5 million across 3 years, with a median of $3.2 million in 2023.
- Annual changes were most pronounced in 2024 — Enterprise Value jumped 79.39% — and 2025, when it slumped 89.62%.
- Zhengye Biotechnology Holding's Enterprise Value stood at $3.8 million in 2023, then surged by 79.39% to $6.8 million in 2024, then plunged by 89.62% to $701156.2 in 2025.
- Business Quant data shows ZYBT's Enterprise Value at $701156.2 in Q4 2025, $2.7 million in Q2 2025, and $6.8 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -882.82 Mn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -3.65 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -5.79 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -2.66 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -886.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -389.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | -164.00 Mn |
| 10 | Zhengye Biotechnology Holding | 86.79 Mn | 79.48 Mn | - | 701,156.20 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 701,156.20 |
| Jun 30, 2025 | 2.65 Mn |
| Dec 31, 2024 | 6.76 Mn |
| Dec 31, 2023 | 3.77 Mn |